
China’s data revolution offers lessons for global health, find experts
China’s vast population and rapid social change make it a “living laboratory” for health research, offering valuable insights into the drivers of non-communicable diseases, environmental exposures, and demographic shifts. The Collection also highlights the growing use of artificial intelligence and digital data, warning that rapid research expansion brings new risks, from fragmented data systems to pressures prioritising quantity over quality.
The Collection authors call for stronger international collaboration to ensure China’s research potential translates into tangible health benefits worldwide. This includes harmonising study design, improving data governance and sharing, and building sustainable funding models to protect the long-term value of cohort data.


“China’s scale makes it a living laboratory for global health, but scale alone isn’t enough. To deliver real impact, research must be rigorous, transparent, and internationally connected.”
Dr Jocalyn Clark
The BMJ’s International Editor and editorial lead for this special collection
The Collection features six analysis articles and an editorial co-authored by experts from The BMJ, Tsinghua University, and the University of Bristol. Together, they chart the evolution of cohort studies in China, from early occupational cohorts to today’s large-scale initiatives, and set out recommendations for the next phase of collaboration and quality assurance.
Main articles in the BMJ Collection on China’s Cohort Studies
Editorial
Enhancing cohort studies in China and international collaboration
A new BMJ Collection examines how well designed, large scale research can benefit global health, but that international collaboration is key to unlocking China’s full potential
Analysis
Landscape analysis of large scale cohort development in China
Zhibin Hu and colleagues advocate for multi-stakeholder collaboration to promote the sustainable development of large scale cohorts in China
International collaboration in cohort studies in China: opportunities and challenges
Zhengming Chen and colleagues outline the key value, opportunities, and challenges of international collaboration in cohort studies in China
Community based cohort studies in China: critical insights for shaping the future of population and public health
Dongfeng Gu and colleagues review community based cohort studies in China, finding strategies to improve the quality and scale of these studies in China and beyond
Breadth versus depth: balancing variables, sample size, and quality in Chinese cohort studies
Weimin Li and colleagues explore the trade-offs and challenges posed by the increasing scale and complexity of cohort studies, highlighting the central argument that “bigger is not always better”
Building sustainable cohort studies in China: a hybrid model for public health research
Xiangmei Chen and colleagues consider the challenges of conducting cohort studies and how they can be overcome
Transforming Chinese cohort studies through artificial intelligence: a new era of population health research
Tien Yin Wong and colleagues explore how artificial intelligence can tackle persistent challenges in Chinese epidemiological studies and analyse the regulatory frameworks and barriers to implementation that must be overcome to ensure equitable, scientifically rigorous population health research
Notes to editors
Funding
This BMJ collection was developed in partnership with West China Hospital, Sichuan University and the First Hospital of Jilin University. The BMJ commissioned, peer reviewed, edited, and made the decisions to publish the articles. John Ji and Jocalyn Clark were the lead editors for The BMJ.
Request an interview with The BMJ international editor, Dr Jocalyn Clark, by contacting the BMJ Group media relations team: mediarelations@bmj.com / +44 (0)7825 118 107
About BMJ Group and BMJ Collections
BMJ Group is a global healthcare knowledge provider and publisher of one of the world’s top five most cited general medical journals, The BMJ. For BMJ Group, collections are an important way of bringing evidence together to address key issues in health and research. BMJ Collections help inform policy and guidelines and influence funding decisions by tackling the most pressing health challenges, policy issues and global priorities.
They combine research, analysis and expert commentary, coordinated and commissioned through our global network of researchers, and are developed with academic institutions, funders, non governmental organisations and international bodies. Drawing on leading journals such as The BMJ, BMJ Innovations and BMJ Global Health, they raise awareness and deliver the latest, most relevant evidence through events, targeted dissemination and thought leadership. https://www.bmj.com/collections

